Results 1 to 10 of about 25,878 (248)

Ocular Adverse Events Associated With Antidepressants: A Large-Scale Data Analysis From the FAERS Database. [PDF]

CNS Neurosci Ther
This decadal FAERS study (2015–2024) identifies 62,020 ocular adverse events (AEs) across 39 antidepressants, highlighting ocular neuromuscular disorders as a key risk. NDDIs show the strongest associations, while SSRIs exhibit the broadest signal spectrum.
Peng Y, Cao Y, Liu H, Ma J, Yang G.
europepmc   +2 more sources

In-vitro studies of phytochemical, Antioxidant, Antibacterial and Enzymatic inhibition of Oxalis corniculata whole plant from South Waziristan Tribal District Pakistan. [PDF]

PLoS One
Ullah I, Shad Bibi N, Sadiq A, Niazy B, Hesam AM.   +4 more
europepmc   +1 more source

Modulation of monoaminergic neurotransmission in substance use disorders: a neuropharmacological perspective focusing on plant-derived metabolites. [PDF]

Front Pharmacol
Sivamaruthi BS, Kesika P, Chaiyasut C, Ragu Varman D.   +3 more
europepmc   +1 more source

Deciphering the mechanisms underlying the dual-target inhibition of carbohydrate-digesting and neurodegenerative enzymes by Syzygium aromaticum (L.) Merr. & L.M. via molecular docking and dynamics simulations. [PDF]

Sci Rep
Ojo OA, Gyebi GA, Iyobhebhe M, Dada S, Daramola T, Ojo AB, Oyebamiji AK, Oyinloye BE, Ajiboye BO.   +8 more
europepmc   +1 more source

Switching Monoamine Oxidase Inhibitors

Drug Intelligence & Clinical Pharmacy, 1985
Substituting one monoamine oxidase inhibitor for another is recommended only after a drug-free interval to avoid hypertensive emergencies. The evidence and mechanism firmly supporting this caution is lacking. We report a case where monoamine oxidase inhibitors were substituted without apparent adverse consequences.
B L, True, B, Alexander, B, Carter
openaire   +2 more sources